Rentschler Biopharma News and Activities

Rentschler Biopharma has a direct presence in 2 countries.

View the org chart displaying its 29 main executives

Most searched biographies at Rentschler Biopharma

• Uwe Bücheler, Interim Chief Executive Officer
• Carol Von Gersdorff, Director
• Rebecca Steinhage, Director

Popular executive movements at Rentschler Biopharma

• Veit Bergendahl will join the company as Chief Operating Officer on Apr. 1, 2026  (posted on February 17 2026).
• Detra Glinatsis has joined the company as Head of Business Development, US  (posted on January 23 2026).
• Benedikt Von Braunmuehl, Chief Executive Officer, has left the company  (posted on January 21 2026).

Click here to view some more movements at Rentschler Biopharma

Create your alert
to follow the executive moves at Rentschler Biopharma.

Rentschler Biopharma has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Rentschler Biopharma

• Together We Build: Rentschler Biopharma blickt auf erfolgreiches Wachstum und positive Standortentwicklung in Milford seit der US-Expansion
• Rentschler Biopharma beruft Dr. Veit Bergendahl zum Chief Operating Officer und in den Vorstand
• Rentschler Biopharma kündigt Veränderungen in der Geschäftsführung und nächste Phase der Unternehmensstrategie an
• Rentschler Biopharma ernennt Detra Glinatsis zum Head of Business Development U.S.
• VarmX und Rentschler Biopharma kooperieren, um neuartige Gerinnungstherapie in Phase 3 und zur Kommerzialisierung voranzubringen
• Rentschler Biopharma Inc. gewinnt "Manufacturer of the Year"Preis für Zentral-Massachusetts
• Rentschler Biopharma und Coriolis Pharma geben strategische Zusammenarbeit für integrierte Biopharma-Lösungen bekannt
• Together We Build: Rentschler Biopharma feiert Baufortschritt der größten Einzelinvestition am Standort Laupheim
• Rentschler Biopharma erweitert seine Dienstleistungen in Japan und Südkorea weiter und wird an der BioProcess International Asia teilnehmen
• Rentschler Biopharma in Laupheim schließt ISO 50001-Zertifizierung für Energiemanagementsystem erfolgreich ab
• View more press releases Close

Social media about Rentschler Biopharma

• Rentschler Biopharma on Wikipedia, Google News & Yahoo Finance
• Rentschler Biopharma on LinkedIn, X (Twitter) & YouTube